Elanco Animal Health Inc
Elanco Animal Health Inc
Insider Sentiment (TTM):
Last Purchase:2026-05-15Last Sale:-Shares Purchased (TTM):53,332Shares Sold (TTM):0
Institutional Sentiment:
As of:2026-03-31Institutional Shares Owned:501,441,923Shares Outstanding:497,700,000Institutional Ownership Pct.:100.75%
Earnings Market Reaction:
Filing Date:2026-08-05Price on Filing Date:N/APrevious Close:N/A% Change:N/A
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 530 | 428 | 545 | 505 | 539 | 487 | 468 | 490 | 416 | 345 | 352 | 369 | |||||
Accounts Receivable Net Current | 1,077 | 1,084 | 873 | 894 | 989 | 970 | 805 | 840 | 999 | 988 | 842 | 911 | |||||
Other Receivables Net Current | 75 | 70 | 67 | 81 | 114 | 90 | 81 | 64 | 81 | 90 | 168 | 224 | |||||
Inventory Net | 1,769 | 1,717 | 1,737 | 1,708 | 1,670 | 1,592 | 1,574 | 1,632 | 1,611 | 1,638 | 1,735 | 1,690 | |||||
Prepaid Expense And Other Assets Current | 346 | 285 | 236 | 305 | 302 | 301 | 287 | 340 | 277 | 338 | 310 | 371 | |||||
Assets Of Disposal Group Including Discontinued Op… | - | - | - | - | - | - | - | - | 627 | 651 | - | - | |||||
Assets Current | 3,797 | 3,584 | 3,458 | 3,493 | 3,614 | 3,440 | 3,215 | 3,366 | 4,011 | 4,050 | 3,407 | 3,565 | |||||
Assets Noncurrent | |||||||||||||||||
Property Plant And Equipment And Finance Lease Rig… | - | - | 1,409 | - | - | - | 993 | - | - | - | - | - | |||||
Property Plant And Equipment Net | 1,411 | 1,395 | - | 1,392 | 1,357 | 1,047 | 993 | 979 | 949 | 949 | 1,026 | 992 | |||||
Goodwill | 4,845 | 4,723 | 4,779 | 4,764 | 4,758 | 4,508 | 4,414 | 4,625 | 4,480 | 4,478 | 5,094 | 4,902 | |||||
Intangible Assets Net Excluding Goodwill | 3,204 | 3,225 | 3,408 | 3,596 | 3,705 | 3,634 | 3,681 | 4,011 | 4,000 | 4,196 | 4,494 | 4,475 | |||||
Other Assets Noncurrent | 304 | 295 | 304 | 306 | 308 | 312 | 311 | 302 | 324 | 346 | 341 | 410 | |||||
Assets | 13,561 | 13,222 | 13,358 | 13,551 | 13,742 | 12,941 | 12,614 | 13,283 | 13,764 | 14,019 | 14,362 | 14,344 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 427 | 372 | 368 | 352 | 368 | 330 | 296 | 259 | 291 | 302 | 270 | 296 | |||||
Employee Related Liabilities Current | - | - | 206 | - | - | - | 177 | - | - | - | 157 | - | |||||
Contract With Customer Liability Current | 450 | 400 | 416 | 376 | 367 | 319 | 332 | 333 | 356 | 318 | 367 | 356 | |||||
Long Term Debt Current | - | - | - | - | - | 44 | 44 | 44 | 213 | 38 | 38 | 39 | |||||
Long Term Debt And Capital Lease Obligations Curre… | 73 | 73 | 74 | 62 | 61 | - | 44 | - | - | - | - | - | |||||
Other Liabilities Current | 902 | 817 | 533 | 665 | 596 | 576 | 466 | 685 | 510 | 574 | 409 | 574 | |||||
Liabilities Current | 1,852 | 1,662 | 1,597 | 1,455 | 1,392 | 1,269 | 1,315 | 1,321 | 1,370 | 1,232 | 1,241 | 1,265 | |||||
Liabilities Noncurrent | |||||||||||||||||
Long Term Debt Noncurrent | - | - | - | - | - | 4,351 | 4,277 | 4,313 | 5,463 | 5,727 | 5,736 | 5,870 | |||||
Long Term Debt And Capital Lease Obligations | 3,845 | 3,918 | 3,943 | 3,962 | 4,148 | - | 4,277 | - | - | - | - | - | |||||
Pension And Other Postretirement Defined Benefit P… | - | - | 158 | - | - | - | 175 | - | - | - | 184 | - | |||||
Deferred Income Tax Liabilities Net | 410 | 366 | 382 | 478 | 496 | 481 | 449 | 539 | 524 | 530 | 567 | 643 | |||||
Other Liabilities Noncurrent | 551 | 467 | 427 | 607 | 638 | 487 | 302 | 587 | 465 | 474 | 411 | 432 | |||||
Liabilities | 6,973 | 6,722 | 6,811 | 6,802 | 6,967 | 6,588 | 6,518 | 6,760 | 7,822 | 7,963 | 8,139 | 8,210 | |||||
Stockholders Equity | |||||||||||||||||
Preferred Stock Value | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 8,878 | 8,858 | 8,870 | 8,854 | 8,839 | 8,819 | 8,817 | 8,804 | 8,790 | 8,777 | 8,777 | 8,763 | |||||
Retained Earnings Accumulated Deficit | -2,071 | -2,125 | -2,182 | -1,906 | -1,872 | -1,883 | -1,950 | -1,942 | -2,306 | -2,256 | -2,288 | -2,147 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -219 | -233 | -141 | -199 | -192 | -583 | -771 | -339 | -542 | -465 | -266 | -482 | |||||
Stockholders Equity | 6,588 | 6,500 | 6,547 | 6,749 | 6,775 | 6,353 | 6,096 | 6,523 | 5,942 | 6,056 | 6,223 | 6,134 | |||||
Liabilities And Stockholders Equity | 13,561 | 13,222 | 13,358 | 13,551 | 13,742 | 12,941 | 12,614 | 13,283 | 13,764 | 14,019 | 14,362 | 14,344 | |||||
Preferred Stock Shares Authorized | 1,000 | 1,000 | 1,000 | - | - | - | 1,000 | - | - | - | - | - | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - | |||||
Common Stock Shares Authorized | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | |||||
Common Stock Shares Issued | 500 | 499 | 497 | 497 | 497 | 496 | 494 | 494 | 494 | 494 | 493 | 493 | |||||
Shares Outstanding | 500 | 499 | 497 | 497 | 497 | 496 | 494 | 494 | 494 | 494 | 493 | 493 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
0/5
Search a metric to start building a table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
0/1
Search a metric to start building a visual
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -8.90% | -6.15% | -4.85% | - | - | - | - | - | - | - | - | - |
| 2025 | 11.91% | 18.98% | 24.23% | 11.35% | 18.99% | 33.80% | 7.73% | 4.63% | 12.96% | -9.10% | -10.24% | -24.72% |
| 2024 | 4.68% | -14.56% | -23.62% | 19.09% | 10.24% | -4.46% | -8.90% | -16.83% | -16.69% | -1.59% | -21.12% | 20.75% |
| 2023 | - | - | - | 2.23% | -7.26% | -26.98% | 15.89% | 39.25% | 41.87% | -2.71% | -20.36% | 5.72% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 2.05 | 2.16 | 2.17 | 2.40 | 2.60 | 2.71 | 2.44 | 2.55 | 2.93 | 3.29 | 2.75 | 2.82 | |||||
| Quick Ratio | 0.91 | 0.95 | 0.93 | 1.02 | 1.18 | 1.22 | 1.03 | 1.06 | 1.55 | 1.68 | 1.10 | 1.19 | |||||
| Working Capital | 1.95B | 1.92B | 1.86B | 2.04B | 2.22B | 2.17B | 1.90B | 2.05B | 2.64B | 2.82B | 2.17B | 2.30B | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 1.06 | 1.03 | 1.04 | 1.01 | 1.03 | 1.04 | 1.07 | 1.04 | 1.32 | 1.31 | 1.31 | 1.34 | |||||
| Interest Coverage TTM | - | - | - | - | 11.22 | 5.36 | 3.58 | 2.61 | -3.61 | -3.63 | -3.31 | -3.25 | |||||
| Debt Ratio | 0.51 | 0.51 | 0.51 | 0.50 | 0.51 | 0.51 | 0.52 | 0.51 | 0.57 | 0.57 | 0.57 | 0.57 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.37 | 0.37 | 0.36 | 0.34 | 0.33 | 0.33 | 0.33 | 0.32 | 0.30 | 0.29 | 0.30 | 0.30 | |||||
| Days Sales Outstanding TTM | 75.11 | 76.61 | 64.95 | 68.93 | 80.91 | 80.72 | 67.71 | 71.75 | 81.21 | 85.25 | 67.72 | 71.69 | |||||
| Receivables Turnover TTM | 4.86 | 4.76 | 5.62 | 5.30 | 4.51 | 4.52 | 5.39 | 5.09 | 4.49 | 4.28 | 5.39 | 5.09 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.39 | -0.48 | -0.47 | 0.07 | 0.87 | 0.75 | 0.68 | 0.41 | -2.54 | -2.63 | -2.50 | -2.32 | |||||
| Free Cash Flow Per Share TTM | 0.62 | 0.60 | 0.54 | 0.85 | 0.83 | 0.70 | 0.80 | 0.77 | 0.86 | 0.56 | 0.27 | -0.15 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 55.36% | 55.06% | 54.99% | 54.96% | 54.73% | 54.89% | 54.88% | 54.69% | 55.19% | 55.28% | 56.28% | 57.33% | |||||
| Operating Profit Margin TTM | -3.31% | -4.03% | -4.75% | -0.35% | 13.22% | 12.11% | 10.99% | 9.25% | -27.69% | -29.58% | -27.05% | -26.50% | |||||
| Net Profit Margin TTM | -3.96% | -4.95% | -4.92% | 0.78% | 9.68% | 8.43% | 7.61% | 4.60% | -27.94% | -29.83% | -27.87% | -26.20% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 11.95% | 10.53% | 6.22% | 3.08% | -0.18% | 1.42% | 0.50% | 2.02% | 3.89% | -1.73% | 0.14% | 27.40% | |||||
| Net Income Growth (1Y) | -145.85% | -164.88% | -168.64% | -82.44% | -134.58% | -128.65% | -127.46% | -117.92% | 1,010.62% | 4,907.69% | 1,478.21% | 766.67% | |||||
| EPS Growth (1Y) | -145.59% | -164.54% | -168.31% | -82.53% | -134.41% | -128.54% | -127.36% | -117.86% | 1,007.02% | 4,886.37% | 1,465.38% | 759.10% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -61.77 | -49.21 | -48.42 | 277.93 | 16.34 | 13.94 | 17.70 | 35.42 | -5.68 | -6.17 | -5.96 | -4.84 | |||||
| P/B TTM | 1.87 | 1.83 | 1.72 | 1.48 | 1.05 | 0.82 | 0.98 | 1.11 | 1.20 | 1.33 | 1.18 | 0.90 | |||||
| P/S TTM | 2.45 | 2.43 | 2.38 | 2.18 | 1.58 | 1.17 | 1.35 | 1.63 | 1.59 | 1.84 | 1.66 | 1.27 | |||||
| Market Cap | 12.29B | 11.91B | 11.23B | 10.01B | 7.09B | 5.20B | 5.98B | 7.26B | 7.13B | 8.03B | 7.34B | 5.54B | |||||
| Enterprise Value | 15.68B | 15.47B | 14.71B | 13.52B | 10.76B | 9.11B | 9.88B | 11.13B | 12.39B | 13.45B | 12.76B | 11.08B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 312.00M | 299.00M | 268.00M | 421.00M | 414.00M | 347.00M | 394.00M | 380.00M | 425.00M | 278.00M | 131.00M | -72.00M | |||||
| Net Debt | 3.39B | 3.56B | 3.47B | 3.52B | 3.67B | 3.91B | 3.90B | 3.87B | 5.26B | 5.42B | 5.42B | 5.54B | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
2026-05-15Purchase
Owner: Simmons, Jeffrey N
Title: PRESIDENT, CEO AND DIRECTOR
Shares: 4,971
Price/Share: $20.09
Value: $99,867.39
Shares Owned: 171,971
Relationship: Director,Officer
Ownership: Indirect
2026-05-15Purchase
Owner: Modi, Rajeev A.
Title: SEE REMARKS
Shares: 4,911
Price/Share: $20.35
Value: $99,938.85
Shares Owned: 160,812
Relationship: Officer
Ownership: Direct
2025-12-12Purchase
Owner: Kurzius, Lawrence Erik
Title: -
Shares: 10,000
Price/Share: $21.30
Value: $213,000.00
Shares Owned: 131,773
Relationship: Director
Ownership: Direct
2025-12-11Purchase
Owner: Vanhimbergen, Robert M
Title: EVP and CFO
Shares: 6,950
Price/Share: $21.64
Value: $150,398.00
Shares Owned: 124,233
Relationship: Officer
Ownership: Direct
2025-12-11Purchase
Owner: Modi, Rajeev A.
Title: SEE REMARKS
Shares: 4,500
Price/Share: $21.33
Value: $95,985.00
Shares Owned: 123,082
Relationship: Officer
Ownership: Direct
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
No data available for chart
2026-03-31
100.75%
Inst. Shares: 501,441,923
Shares Outstanding: 497,700,000
2025-12-31
99.57%
Inst. Shares: 494,246,785
Shares Outstanding: 496,400,000
2025-09-30
107.54%
Inst. Shares: 534,268,329
Shares Outstanding: 496,800,000
2025-06-30
103.54%
Inst. Shares: 514,202,695
Shares Outstanding: 496,600,000
2025-03-31
95.48%
Inst. Shares: 472,720,419
Shares Outstanding: 495,100,000
Elanco Animal Health Inc (ELAN) — SEC Financial Statements & Analysis
Elanco Animal Health Inc (ELAN) is a pharmaceutical preparations company. Elanco Animal Health Inc trades on NYSE as: ELAN. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Elanco Animal Health Inc reported a 11.95% year-over-year revenue growth, a Gross Profit Margin of 55.36% (TTM), a Debt-to-Equity ratio of 1.06x, a Price-to-Sales (P/S) ratio of 2.45x (TTM), a Price-to-Book (P/B) ratio of 1.87x (TTM), at a market cap of $12.29B. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 11.95%
- Gross Profit Margin TTM
- 55.36%
- Debt To Equity
- 1.06x
- P/S TTM
- 2.45x
- P/B TTM
- 1.87x
- Market Cap
- $12.29B
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Elanco Animal Health Inc in?
Elanco Animal Health Inc (ELAN) operates in the Pharmaceutical Preparations industry.
What is ELAN's market cap?
Elanco Animal Health Inc (ELAN) has a market capitalization of $12.29B as of 2026-06-30.
What exchange does ELAN trade on?
Elanco Animal Health Inc (ELAN) trades on the NYSE.